Whoop has unveiled plans to enhance its fitness wearable capabilities by introducing in-app access to on-demand licensed clinicians for users in the United States. This initiative comes as part of a broader suite of health and AI-driven features, set to roll out globally. The new functionalities aim to connect users’ continuous biometric data with real-time medical guidance, enriching the overall experience for Whoop’s members.
While many of these innovative features will be included in the membership cost, the option for live video consultations with healthcare professionals will come at an additional fee. Specific pricing details are expected to be announced when this feature launches this summer.
In a statement, Ed Baker, the chief product officer at Whoop, emphasized the company’s commitment to delivering value to its members, highlighting that these upcoming features represent some of the most significant advancements the company has made. With over 2.5 million users worldwide, Whoop aims to enhance the understanding of individual health through the use of its device, which continuously collects biometric data.
The medical consultations will begin with a thorough evaluation of data gathered from the device, combined with any available blood work and medical history. Whoop has clarified that the video consultations are intended to supplement existing healthcare, rather than replace primary care providers or emergency services. The company did not comment on whether the service could issue prescriptions.
Moreover, Whoop has established a partnership with health records management platform HealthEx, enabling users to track their diagnoses, medications, and procedures directly within the Whoop app. Users will also benefit from AI-driven personalized coaching and proactive check-in reminders, further integrating technology into personal health management.
This announcement follows a recent interaction with U.S. regulatory authorities, as the FDA had previously issued a warning to Whoop regarding its Blood Pressure Insights feature, classifying it as an unauthorized medical device. However, new FDA guidelines issued in January have since allowed wellness devices to use optical sensing for blood pressure measurements, provided they refrain from making “medical-grade” diagnostic claims.
